Literature DB >> 10685852

Weight gain following unilateral pallidotomy in Parkinson's disease.

W G Ondo1, L Ben-Aire, J Jankovic, E Lai, C Contant, R Grossman.   

Abstract

OBJECTIVE: To determine the clinical correlates and infer pathogenesis of weight gain following pallidotomy in patients with Parkinson's disease (PD).
BACKGROUND: Surgical ablation of the globus pallidus internus (GPi) improves levodopa induced dyskinesias, moderately improves most other "cardinal" manifestations of PD, and has been noted to result in increased weight.
METHODS: We incorporated Unified Parkinson's Disease Rating Scales (UPDRS) subscales, the Beck depression inventory and feeding questionnaire data into a linear regression model in order to determine which post-surgical change(s) may lead to weight gain over the first year following pallidotomy, n = 60.
RESULTS: The mean weight gain 1 year after pallidotomy was 4.0 +/- 4.1 kg. Improvement in "off" motor scores (P < 0.005), especially gait subscores (P<0.0001), and to a lesser extent improvement in "on" motor scores (P<0.05) predicted weight gain. Changes in dyskinesia ratings, mood, food intake, dysphagia, levodopa dose, weight loss in the year prior to pallidotomy, age, and duration of PD did not correlate with subsequent weight gain.
CONCLUSION: The high correlation between post-pallidotomy weight gain and "off" motor scores, suggests that this phenomenon is related to some change in underlying homeostasis associated with changes in the cardinal manifestations of PD itself, rather than secondary changes resultant from the surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685852     DOI: 10.1034/j.1600-0404.2000.101002079.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus.

Authors:  Christelle Baunez; Marianne Amalric; Trevor W Robbins
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Body weight gain in patients with bilateral deep brain stimulation for dystonia.

Authors:  Marc E Wolf; Hans-Holger Capelle; Götz Lütjens; Anne D Ebert; Michael G Hennerici; Joachim K Krauss; Christian Blahak
Journal:  J Neural Transm (Vienna)       Date:  2015-08-22       Impact factor: 3.575

Review 3.  Weight loss in Parkinson's disease.

Authors:  Kenichi Kashihara
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

4.  Weight change after globus pallidus internus or subthalamic nucleus deep brain stimulation in Parkinson's disease and dystonia.

Authors:  Kelly A Mills; Rebecca Scherzer; Philip A Starr; Jill L Ostrem
Journal:  Stereotact Funct Neurosurg       Date:  2012-08-23       Impact factor: 1.875

5.  Nutritional therapies in Parkinson's disease.

Authors:  Marian L Evatt
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

6.  Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD.

Authors:  Eric M Lee; Ashish Kurundkar; Gary R Cutter; He Huang; Barton L Guthrie; Ray L Watts; Harrison C Walker
Journal:  Brain Behav       Date:  2011-09       Impact factor: 2.708

7.  Chronic spinal cord electrical stimulation protects against 6-hydroxydopamine lesions.

Authors:  Amol P Yadav; Romulo Fuentes; Hao Zhang; Thais Vinholo; Chi-Han Wang; Marco Aurelio M Freire; Miguel A L Nicolelis
Journal:  Sci Rep       Date:  2014-01-23       Impact factor: 4.379

8.  Stereotactic surgery for eating disorders.

Authors:  Bomin Sun; Wei Liu
Journal:  Surg Neurol Int       Date:  2013-04-17

Review 9.  Mechanisms of body weight fluctuations in Parkinson's disease.

Authors:  Andrea Kistner; Eugénie Lhommée; Paul Krack
Journal:  Front Neurol       Date:  2014-06-02       Impact factor: 4.003

10.  Weight Gain following Pallidal Deep Brain Stimulation: A PET Study.

Authors:  Paul Sauleau; Sophie Drapier; Joan Duprez; Jean-François Houvenaghel; Thibaut Dondaine; Claire Haegelen; Dominique Drapier; Pierre Jannin; Gabriel Robert; Florence Le Jeune; Marc Vérin
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.